2022
DOI: 10.1016/j.pulmoe.2021.07.007
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 as a trigger of eosinophilic pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…There have been small studies on rhinovirus and respiratory syncytial virus, showing slight elevation of the BAL eosinophil fraction due to infection [9,10]. However, except for a few case reports of in uenza (H1N1) and COVID-19 [11][12][13], there are no reports of cases of eosinophilic pneumonia diagnosed with signi cant BAL eosinophil fraction elevation due to respiratory virus infection.…”
Section: Discussionmentioning
confidence: 99%
“…There have been small studies on rhinovirus and respiratory syncytial virus, showing slight elevation of the BAL eosinophil fraction due to infection [9,10]. However, except for a few case reports of in uenza (H1N1) and COVID-19 [11][12][13], there are no reports of cases of eosinophilic pneumonia diagnosed with signi cant BAL eosinophil fraction elevation due to respiratory virus infection.…”
Section: Discussionmentioning
confidence: 99%
“…In these two patients, eosinophilic pneumonia was probably caused by parainfluenza infection since there was no other obvious cause. Although there have been reports of cases of eosinophilic pneumonia with a marked elevation of BAL eosinophil fraction in influenza virus infection and COVID-19 [24][25][26], there are no reports of eosinophilic pneumonia caused by parainfluenza virus. There has been a case report of parainfluenza virus pneumonia; however, the increase of BAL eosinophils was mild and not eosinophilic pneumonia [27].…”
Section: Discussionmentioning
confidence: 99%
“…Since AEP can be caused by infections, we cannot rule out the possibility that the SARS-CoV-2 infection also has this evolution. Three previous studies describe AEP after SARS-CoV-2 infection, raising the hypothesis that it is a predisposing factor for the development of the disease [3][4][5]. The usual treatment for AEP involves the administration of corticosteroids in high doses to alleviate inflammation and inhibit the immune system.…”
Section: Discussionmentioning
confidence: 99%